Last edition
News about "Acute Otitis Media"
Alembic Pharma Gets US FDA Final Approval for Otic Suspension
Alembic Pharmaceuticals receives US FDA final approval for generic ciprofloxacin and dexamethasone otic suspension, targeting specified ear infections. The product’s US market is valued at USD 110 million.
Acute Otitis Media | 19/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members